Chemomab Therapeutics Ltd. (CMMB)
USD 1.59
(-3.64%)
USD 1.59
(-3.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 66.82 Thousand | 57.77 Thousand | 34.02 Thousand | 79.99 Thousand | 281.9 Thousand | 66 Thousand |
| Gross Profit | -66.82 Thousand | -57.77 Thousand | -34.02 Thousand | -79.99 Thousand | -281.9 Thousand | -66 Thousand |
| Operating Expenses | 25.45 Million | 28.53 Million | 12.36 Million | 5.97 Million | 19.32 Million | 12.96 Million |
| Selling, General and Administrative Expenses | 7.07 Million | 11.55 Million | 6.03 Million | 1.28 Million | 5.98 Million | 5.45 Million |
| Research and Development Expenses | 18.38 Million | 16.97 Million | 6.33 Million | 4.68 Million | 13.34 Million | 7.51 Million |
| Other Expenses | - | - | - | 749 Thousand | 3.35 Million | - |
| Cost and Expenses | 25.45 Million | 28.53 Million | 12.36 Million | 5.97 Million | 19.61 Million | 13.03 Million |
| Operating Income | -25.45 Million | -28.53 Million | -12.4 Million | -5.97 Million | -19.61 Million | -13.03 Million |
| Interest Expense | - | 353 Thousand | 111.07 Thousand | 6000.00 | 9000.00 | - |
| Income Tax Expense | - | -534 Thousand | 77 Thousand | -21 Thousand | 1.00 | 306 Thousand |
| Earnings before Tax | -24.22 Million | -28.18 Million | -12.47 Million | -5.95 Million | -27.21 Million | -13.49 Million |
| Net Income | -24.22 Million | -27.64 Million | -12.55 Million | -5.93 Million | -27.21 Million | -13.79 Million |
| Earnings Per Share Basic | -2.06 | -2.43 | -1.21 | -3.20 | -15.80 | -21.84 |
| Earnings Per Share Diluted | -2.06 | -2.43 | -1.21 | -3.20 | -15.80 | -21.84 |
| Weighted Average Shares Outstanding | 11.74 Million | 11.37 Million | 10.37 Million | 1.85 Million | 1.72 Million | 631.7 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 11.74 Million | 11.37 Million | 10.37 Million | 1.85 Million | 1.72 Million | 631.7 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -25.39 Million | -28.47 Million | -12.33 Million | -5.94 Million | -26.92 Million | -13.35 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 26.9 Thousand | - | 16.17 Thousand | 66.82 Thousand | 18.93 Thousand | 15.81 Thousand |
| Gross Profit | -26.9 Thousand | - | -16.17 Thousand | -66.82 Thousand | -18.93 Thousand | -15.81 Thousand |
| Operating Expenses | 3.72 Million | 4.09 Million | 3.87 Million | 25.32 Million | 4.33 Million | 8.19 Million |
| Selling, General and Administrative Expenses | 836.93 Thousand | 946.38 Thousand | 759.13 Thousand | - | 986.8 Thousand | 3.17 Million |
| Research and Development Expenses | 2.89 Million | 3.14 Million | 3.11 Million | - | 3.34 Million | 5.02 Million |
| Other Expenses | - | - | - | - | - | - |
| Cost and Expenses | 3.75 Million | 4.09 Million | 3.88 Million | 25.39 Million | 4.35 Million | 8.19 Million |
| Operating Income | -3.75 Million | -4.09 Million | -3.88 Million | -25.39 Million | -4.35 Million | -8.19 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | -2.00 | -16.75 Thousand | -1.00 | -1.00 | -54.82 Thousand | 34 Thousand |
| Earnings before Tax | -3.61 Million | -3.91 Million | -3.45 Million | -24.15 Million | -4.12 Million | -7.93 Million |
| Net Income | -3.61 Million | -3.91 Million | -3.45 Million | -24.15 Million | -4.06 Million | -7.97 Million |
| Earnings Per Share Basic | -0.25 | -0.28 | -0.27 | - | -0.34 | -0.72 |
| Earnings Per Share Diluted | -0.25 | -0.28 | -0.27 | - | -0.34 | -0.72 |
| Weighted Average Shares Outstanding | 14.3 Million | 14.2 Million | 13.01 Million | 11.74 Million | 11.82 Million | 11.08 Million |
| Weighted Average Shares Outstanding (Diluted) | 14.3 Million | 14.2 Million | 13.01 Million | 11.74 Million | 11.82 Million | 11.08 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -3.72 Million | -4.09 Million | -3.87 Million | - | -4.33 Million | -8.17 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
AW1
DNDDF
000885
ALFUW
RDX
HARIOMPIPE